Advanced in Ependymoma

Antonio G. Ruggiero

Rome, IT 
Advanced in Ependymoma
Rome, IT 
OverviewLocationsClinical Research

Overview

Antonio Ruggiero practices in Rome, Italy. Mr. Ruggiero is rated as an Advanced expert by MediFind in the treatment of Ependymoma. His top areas of expertise are Ependymoma, Gliomatosis Cerebri, Glioma, Splenectomy, and Appendectomy.

His clinical research consists of co-authoring 170 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 1 clinical trial in the study of Ependymoma.

Gender
Male

Locations

Rome, Italy
Other Locations
Sacro Cuore, 00168, Italy
Milan, Italy
Macerata, Italy
Via Dei Vestini 31, Chieti, 66100, Italy
Porto Potenza Picena, 62018, Italy
Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1b/2 Study of Abemaciclib in Combination With Irinotecan and Temozolomide (Part A) and Abemaciclib in Combination With Temozolomide (Part B) in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors and Abemaciclib in Combination With Dinutuximab, GM-CSF, Irinotecan, and Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Neuroblastoma (Part C)
A Phase 1b/2 Study of Abemaciclib in Combination With Irinotecan and Temozolomide (Part A) and Abemaciclib in Combination With Temozolomide (Part B) in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors and Abemaciclib in Combination With Dinutuximab, GM-CSF, Irinotecan, and Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Neuroblastoma (Part C)
Enrollment Status: Completed
Publish Date: October 07, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Irinotecan, Temozolomide
Study Phase: Phase 1/Phase 2

170 Total Publications

Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series.
Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series.
Journal: Tumori
Published: November 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ruggiero's expertise for a condition
ConditionClose
      View All 13 Advanced Conditions
      View All 56 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile